Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma

被引:5
作者
Ponto, Jay [1 ]
Bell, R. Bryan [1 ]
机构
[1] Providence Canc Inst, Earle A Chiles Res Inst, Robert W Franz Canc Ctr, 4805 NE Glisan St Suite 2N35, Portland, OR 97213 USA
关键词
Melanoma; Immunotherapy; Adaptive therapy; Head and neck; Metastasis; Systemic therapy; Malignancy; STAGE-III MELANOMA; DABRAFENIB PLUS TRAMETINIB; LONG-TERM SURVIVAL; DOUBLE-BLIND; HIGH-RISK; IV MELANOMA; RECOMBINANT INTERLEUKIN-2; COMPLETE RESECTION; BRAF INHIBITION; POOLED ANALYSIS;
D O I
10.1016/j.coms.2021.11.010
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
[No abstract available]
引用
收藏
页码:315 / 324
页数:10
相关论文
共 65 条
[1]   Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma [J].
Amaria, Rodabe N. ;
Reddy, Sangeetha M. ;
Tawbi, Hussein A. ;
Davies, Michael A. ;
Ross, Merrick, I ;
Glitza, Isabella C. ;
Cormier, Janice N. ;
Lewis, Carol ;
Hwu, Wen-Jen ;
Hanna, Ehab ;
Diab, Adi ;
Wong, Michael K. ;
Royal, Richard ;
Gross, Neil ;
Weber, Randal ;
Lai, Stephen Y. ;
Ehlers, Richard ;
Blando, Jorge ;
Milton, Denai R. ;
Woodman, Scott ;
Kageyama, Robin ;
Wells, Daniel K. ;
Hwu, Patrick ;
Patel, Sapna P. ;
Lucci, Anthony ;
Hessel, Amy ;
Lee, Jeffrey E. ;
Gershenwald, Jeffrey ;
Simpson, Lauren ;
Burton, Elizabeth M. ;
Posada, Liberty ;
Haydu, Lauren ;
Wang, Linghua ;
Zhang, Shaojun ;
Lazar, Alexanderj ;
Hudgens, Courtney W. ;
Gopalakrishnan, Vancheswaran ;
Reuben, Alexandre ;
Andrews, Miles C. ;
Spencer, Christine N. ;
Prieto, Victor ;
Sharma, Padmanee ;
Allison, James ;
Tetzlaff, Michael T. ;
Wargo, Jennifer A. .
NATURE MEDICINE, 2018, 24 (11) :1649-+
[2]   Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial [J].
Amaria, Rodabe N. ;
Prieto, Peter A. ;
Tetzlaff, Michael T. ;
Reuben, Alexandre ;
Andrews, Miles C. ;
Ross, Merrick J. ;
Glitza, Isabella C. ;
Cormier, Janice ;
Hwu, Wen-Jen ;
Tawbi, Hussein A. ;
Patel, Sapna P. ;
Lee, Jeffrey E. ;
Gersbenwaid, Jeffrey E. ;
Spencer, Christine N. ;
Gopalakrishnan, Vancheswaran ;
Bassett, Roland ;
Simpson, Lauren ;
Mouton, Rosalind ;
Hudgens, Courtney W. ;
Zhao, Li ;
Zhu, Haifeng ;
Cooper, Zachary A. ;
Wani, Khalida ;
Lazar, Alexander ;
Hwu, Patrick ;
Diab, Adi ;
Wong, Michael K. ;
McQuade, Jennifer L. ;
Royal, Richard ;
Lucci, Anthony ;
Burton, Elizabeth M. ;
Reddy, Sangeetha ;
Sharma, Padmanee ;
Allison, James ;
Futreal, Phillip A. ;
Woodman, Scott E. ;
Davies, Michael A. ;
Wargo, Jennifer A. .
LANCET ONCOLOGY, 2018, 19 (02) :181-193
[3]   Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial [J].
Ascierto, Paolo A. ;
Del Vecchio, Michele ;
Mandala, Mario ;
Gogas, Helen ;
Arance, Ana M. ;
Dalle, Stephane ;
Cowey, C. Lance ;
Schenker, Michael ;
Grob, Jean-Jacques ;
Chiarion-Sileni, Vanna ;
Marquez-Rodas, Ivan ;
Butler, Marcus O. ;
Maio, Michele ;
Middleton, Mark R. ;
de la Cruz-Merino, Luis ;
Arenberger, Petr ;
Atkinson, Victoria ;
Hill, Andrew ;
Fecher, Leslie A. ;
Millward, Michael ;
Khushalani, Nikhil, I ;
Queirolo, Paola ;
Lobo, Maurice ;
de Pril, Veerle ;
Loffredo, John ;
Larkin, James ;
Weber, Jeffrey .
LANCET ONCOLOGY, 2020, 21 (11) :1465-1477
[4]   Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial [J].
Ascierto, Paolo A. ;
McArthur, Grant A. ;
Dreno, Brigitte ;
Atkinson, Victoria ;
Liszkay, Gabrielle ;
Di Giacomo, Anna Maria ;
Mandala, Mario ;
Demidov, Lev ;
Stroyakovskiy, Daniil ;
Thomas, Luc ;
de la Cruz-Merino, Luis ;
Dutriaux, Caroline ;
Garbe, Claus ;
Yan, Yibing ;
Wongchenko, Matthew ;
Chang, Ilsung ;
Hsu, Jessie J. ;
Koralek, Daniel O. ;
Rooney, Isabelle ;
Ribas, Antoni ;
Larkin, James .
LANCET ONCOLOGY, 2016, 17 (09) :1248-1260
[5]   High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].
Atkins, MB ;
Lotze, MT ;
Dutcher, JP ;
Fisher, RI ;
Weiss, G ;
Margolin, K ;
Abrams, J ;
Sznol, M ;
Parkinson, D ;
Hawkins, M ;
Paradise, C ;
Kunkel, L ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116
[6]   Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma [J].
Blank, Christian U. ;
Rozeman, Elisa A. ;
Fanchi, Lorenzo F. ;
Sikorska, Karolina ;
van de Wiel, Bart ;
Kvistborg, Pia ;
Krijgsman, Oscar ;
van den Braber, Marlous ;
Philips, Daisy ;
Broeks, Annegien ;
van Thienen, Johannes, V ;
Mallo, Henk A. ;
Adriaansz, Sandra ;
ter Meulens, Sylvia ;
Pronk, Loes M. ;
Grijpink-Ongering, Lindsay G. ;
Bruining, Annemarie ;
Gittelman, Rachel M. ;
Warren, Sarah ;
van Tinteren, Harm ;
Peeper, Daniel S. ;
Haanen, John B. A. G. ;
van Akkooi, Alexander C. J. ;
Schumacher, Ton N. .
NATURE MEDICINE, 2018, 24 (11) :1655-+
[7]   A NEW MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY - CTLA-4 [J].
BRUNET, JF ;
DENIZOT, F ;
LUCIANI, MF ;
ROUXDOSSETO, M ;
SUZAN, M ;
MATTEI, MG ;
GOLSTEIN, P .
NATURE, 1987, 328 (6127) :267-270
[8]   Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study [J].
Callahan, Margaret K. ;
Kluger, Harriet ;
Postow, Michael A. ;
Segal, Neil H. ;
Lesokhin, Alexander ;
Atkins, Michael B. ;
Kirkwood, John M. ;
Krishnan, Suba ;
Bhore, Rafia ;
Horak, Christine ;
Wolchok, Jedd D. ;
Sznol, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04) :391-+
[9]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[10]   Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2 [J].
Clark, Joseph, I ;
Curti, Brendan ;
Davis, Elizabeth J. ;
Kaufman, Howard ;
Amin, Asim ;
Alva, Ajjai ;
Logan, Theodore F. ;
Hauke, Ralph ;
Miletello, Gerald P. ;
Vaishampayan, Ulka ;
Johnson, Douglas B. ;
White, Richard L. ;
Wiernik, Peter H. ;
Dutcher, Janice P. .
JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (04) :888-892